ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Fasenra, Injektionslösung - 
66582001 AstraZeneca AG
Fasenra, Injektionslösung08.06.2018
  08.06.2018
Benralizumab (R03DX10) 
WHO-DDD07.06.2023
03.04.50. 
03.04.50. 
B  
Yes 
IPCI
2319.39Yes
    
10 %2605.30
7680665820019Biotechnologika
7452343 
Composition
benralizumabum 30 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabilia q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution
 
 
Active AgentDose
Benralizumabum30 mg/ml
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20
Trehalosum Dihydricum
Source
Data was imported : 06.06.2019 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2020 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home